Quote:The Foster City, California-based drugmaker will now have access to Galapagos' research base of more than 500 scientists and will nominate two members to the Belgian-Dutch firm's board of directors after the deal closes. The transaction is expected to close late in the third quarter of 2019.
one of the material events' 8k'd that won't come as a surprise imo .. is seeing
a BoD add to Innovation Pharma's BOD over the coming weeks/months
imo that is one signal NR recognizes re: future uplist out of the OTC cesspool and CANT ignore
Quote:
The two companies partnered with each other in 2015 on a drug to treat rheumatoid arthritis, called filgotinib, which it plans to seek approval for this year. Under an amended agreement, also announced Sunday, Galapagos will have more involvement in the global strategy for the drug and participate "more broadly in the commercialization of the product in Europe," Gilead said.
https://finance.yahoo.com/news/gilead-science...08821.html
thx for the read ..
4kids
Quote:
2
